The use of GLP-1 drugs such as Ozempic is surging among Canadians
And reshaping the food industry
And reshaping the food industry
Researchers working to identify drug combinations to treat people with obesity, Type 2 diabetes
Read MoreFewer surgery complications and shorter hospital stays
Read MoreThrowing more money into the existing system won’t work
Read MoreResearch explores the impact of obesity-related stigma on young people – and how to end it
Read MoreLink could hold the key to improving immune responses against COVID-19 and other viruses
Read MoreActive students have better grades, enhanced memory, lower absenteeism and better behaviour
Read MoreImmunology is at the centre of virtually every chronic disease
Read MoreIt’s time for Canada to regulate marketing food to kids. But regulating marketing is no cakewalk
Read MoreSpecialized obesity care is more accessible than ever thanks to increase in virtual health care during pandemic, say researchers
Read More